483
BioMarin Pharmaceutical, Inc.BioMarin Pharmaceutical, Inc. – FDA 483, Apr 2, 2021
Record Details
An FDA inspection of BioMarin Pharmaceutical, Inc. in Novato, CA, a drug substance manufacturer, revealed two significant observations. The firm lacked written procedures for requesting and shipping samples to control laboratories and for receiving, reviewing, and filing test results from contract laboratories. These deficiencies indicate inadequate control over critical quality processes involving external laboratories.
View Company Profile
ID · 68119bf5-5042-4336-9c03-7fde3f113010
Other documents for BioMarin Pharmaceutical, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.